Cystic Fibrosis: A cure for all


Cystic Fibrosis conference has created a platform for all the Pulmonologists and Researchers to share their innovative views about this multi system chronic disease. There are different techniques and methods involved which influenced human health with the help of safe medicines and techniques.

Cystic fibrosis is the most typical, critical, recessively genetic disease of Caucasian populations. Genotyping technology has some limitations which includes the choice of mutations to be tested, and also the clinical context in which the test is administered. It affects approximately over 70,000 people worldwide. This happens because of the mutations in the CFTR gene sequence. These all manifestations can influence the genetic information. It is often challenging in clinical Cystic fibrosis to interpret molecular genetic results, and to integrate them.

To know more about this evolving topic let us join the upcoming huge conference i.e. International conference on Cystic Fibrosis which is going to be held during September 20-21, 2018 at Dubai, UAE which will be a definitively informative platform for Scientists, Researchers, Pulmonologists, Surgeons, Biologists, Paediatricians and many more.

Topics for the discussion include:
  • ·         Clinical Cystic fibrosis
  • ·         Cystic fibrosis and Diabetes
  • ·         Cystic fibrosis and Neonatology
  • ·         Cystic fibrosis and Respiratory care
  • ·         Immunology and Pulmonology
  • ·         Genetics of Cystic fibrosis
  • ·         Cystic fibrosis Treatment and Management
  • ·         Clinical Trials in Cystic fibrosis and many more


For further information, kindly visit Cystic fibrosis 2018
Best Regards
Edward William
Program Manager
Cystic fibrosis 2018
Kemp House152 City Road, London, UK
Tel: +1 702-508-5200 Ext: 8122
E-mail: cysticfibrosis@healthconferences.org



Comments

Post a Comment

Popular posts from this blog

Biomarkers could lead to better treatments for CF patients

Image
Recently two new biological markers are identified for cystic fibrosis (CF), a inherited disease which affects children and young adults, leaving them with lifelong health complications including gastrointestinal problems and persistent lung infections.  The recent research shed new light on the underlying mechanisms of Cystic Fibrosis which could lead to improved prognosis and exceptional therapies for a disease which is quite variable, affecting different children in different ways. There are chemical signatures in sweat that tell us an infant has CF or not. The chemical indicators detected in sweat that could complement the gold standard for CF diagnosis is with the help of sweat chloride test. The test is commonly used in universal neonatal screening programs and measures the concentrations of salt. Increased sweat chloride confirms that an infant actually has CF. "Sweat contains lots of information related to human health and there are also some unexpected chemical
Read more
Image
Cystic Fibrosis Could Interfere With Children’s Sleep Sleep disruptions in kids with chronic sicknesses are common. There are variety of underlying etiologies for these sleep issues, together with disease symptoms or characteristics adore coughing, itching, or pain, and/or disease management problems adore night time blood-glucose observance. Further, once a child has been diagnosed with a chronic disease, there are variety of changes to daily routines and parenting behavior. In particular, parents of children with chronic disease tend to be additional lenient with routines, which often leads to raised co-sleeping (or bed sharing). Children with cystic fibrosis sleep less and experience extra sleep interruptions than healthy children, even when the illness is well-managed and stable. Children with Cystic fibrosis have higher sleep-disturbance and sleep-apnea scores, and lower Oxygen levels throughout sleep. The sleeping disorders have an impact on the children’s mood, behavior
Read more

Stem Cells as a Viable Therapeutic for Cystic fibrosis

Image
For stem cell therapy to serve as a viable therapeutic for CF the use of heterologous or gene corrected autologous stem cells which are capable of infusing back into the CF airways and perform the desired role of Chloride secretion would be required. A recent study in experimental animal model for CF has reported the usefulness of MSC as an attractive therapeutic in murine model of CF lung infection and inflammation. In this model, MSCs were shown to improve gross lung pathology and decreased the cellular recruitment into the lung, furthermore MSCs shifted the pulmonary cell predominance from neutrophils to an evenly distributed predominance of macrophages and neutrophils, thus promoting the resolution of infection in CF lung, since a predominately neutrophilic inflammation observed in CF airways is responsible for inflicting a tremendous tissue damage and an even distribution of macrophages would insure a better response to the infection through cell mediated immunity. For stem
Read more